Author:
Shah Sarthak,Saravanakumar Sanjeev,Conroy Dylan,Sowmiyanarayanan Srinivas,Singh Rahul,Pepin Abigail,Rashid Harris,Danner Malika T,Krishnan Pranay,Lei Siyuan,Rashid Abdul,Suy Simeng,Kataria Shaan,Aghdam Nima,Collins Sean
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy;Fowler JF;Acta Oncol,2005
2. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer;Kishan AU;JAMA Netw Open,2019
3. What degree of accuracy is required and can be achieved in photon and neutron therapy?;Mijnheer BJ;Radiother Oncol,1987
4. International Atomic Energy Agency. Radiation dose in radiotherapy from prescription to delivery. Proceedings of the Interregional Seminar for Europe, the Middle East and Africa organized by the International Atomic Energy Agency in co-operation with the European Society for Therapeutic Radiology and Oncology and held in Leuven, 16-20 September 1991. International Atomic Energy Agency, Vienna; https://inis.iaea.org/search/search.aspx?orig_q=RN:25033644.
5. Prostate stereotactic body radiation therapy: an overview of toxicity and dose response;Wang K;Int J Radiat Oncol Biol Phys,2021